ISRCTN27929536已完成不适用
The ACTIVE study: a multicentre randomised, double-blind, controlled trial of laparoscopic versus open surgery for acute cholecystitis in adults
Italian Polispecialistic Society of Young Surgeons (Italy)0 个研究点目标入组 144 人开始时间: 2006年12月21日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 144
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Adult patients (more than 18 years)
- •2. Clinical (pain, fever more than 37.5°C, White Blood Cells (WBC) more than 10,000/microL), and ultrasound evidence of cholecystitis
- •3. American Surgical Association (ASA) grade I to III patients
- •4. Informed consent
- •5. Less than 72 hours from onset
排除标准
- •1. Informed consent refusal
- •2. Choledocholithiasis
- •3. Generalised peritonitis
- •4. Previous abdominal surgical procedures
- •5. Patients with an intra-operative findings of different pathology will be excluded from the study
- •6. Apache II score more than ten
研究者
相似试验
已完成
不适用
A randomised study of two schedules of radiotherapy or chemotherapy in elderly patients with high grade gliomaMalignant glioma, grade 3-4 or 4Malignant neoplasm of brainCancerISRCTN81470623ordic Clinical Brain Tumor Study group (Sweden)342
进行中（未招募）
不适用
A research study to evaluate the effect of 3 different doses of a new medicine (glycopyrrolate) administered in combination with a licenced medicine (Foster®) in patients with uncontrolled asthmauncontrolled asthmaMedDRA version: 17.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2013-003043-36-DECHIESI FARMACEUTICI S.p.A220
进行中（未招募）
不适用
A clinical trial to assess the most efficacious dose of bronchodilator, Glycopyrrolate, to add to the existing treatment (Foster®, Beclomethasone + Formoterol) for the development of a new triple therapy in a single aerosol for the treatment of patients suffering from severe COPD.Chronic Obstructive Pulmonary DiseaseEUCTR2011-003588-31-PLChiesi Farmaceutici S.p.A.180
进行中（未招募）
不适用
A research study to evaluate the effect of 3 different doses of a new medicine (glycopyrrolate) administered in combination with a licenced medicine (Foster®) in patients with uncontrolled asthmauncontrolled asthmaMedDRA version: 16.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2013-003043-36-GBCHIESI FARMACEUTICI S.p.A220
进行中（未招募）
不适用
A clinical trial to assess the most efficacious dose of bronchodilator, Glycopyrrolate, to add to the existing treatment (Foster®, Beclomethasone + Formoterol) for the development of a new triple therapy in a single aerosol for the treatment of patients suffering from severe COPD.Chronic Obstructive Pulmonary DiseaseEUCTR2011-003588-31-HUChiesi Farmaceutici S.p.A.180